Green Light Filtering Glasses During Traumatic Brain Injury Rehabilitation
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07931638. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy of Narrow-Band Green Light Filtering Glasses for Symptom Management and Rehabilitation Participation During Traumatic Brain Injury Rehabilitation: A Randomized Crossover Pilot Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this pilot study is to evaluate whether narrow-band green light filtering glasses improve symptom management and participation in rehabilitation among individuals recovering from traumatic brain injury (TBI). Common post-traumatic symptoms such as photophobia, headaches, difficulty concentrating, anxiety, and sleep disturbances may interfere with engagement in rehabilitation therapies and limit recovery. This study will examine whether use of green light filtering eyewear reduces symptom burden and improves participation in physical, occupational, and speech therapy sessions. Findings will provide preliminary evidence regarding the feasibility and potential clinical utility of green light filtering eyewear as a non-pharmacologic intervention during rehabilitation.
Study identification
- NCT ID
- NCT07931638
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2026 (Estimated)
- Primary completion
- Oct 31, 2027 (Estimated)
- Completion
- Dec 31, 2027 (Estimated)
- Last update posted
- Nov 12, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Casa Colina Hospital and Centers for Healthcare | Pomona | California | 91767 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07931638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.